Tower Bridge Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-617
| Closed | -$594K | – | 196 |
|
|
2024
Q1 | $594K | Hold |
617
| – | – | 0.06% | 146 |
|
|
2023
Q4 | $542K | Hold |
617
| – | – | 0.05% | 161 |
|
|
2023
Q3 | $508K | Hold |
617
| – | – | 0.05% | 158 |
|
|
2023
Q2 | $443K | Buy |
617
+100
| +19% | +$71.9K | 0.04% | 156 |
|
|
2023
Q1 | $425K | Buy |
517
+200
| +63% | +$164K | 0.03% | 181 |
|
|
2022
Q4 | $229K | Hold |
317
| – | – | 0.02% | 223 |
|
|
2022
Q3 | $218K | Buy |
+317
| New | +$218K | 0.02% | 217 |
|
|
2022
Q2 | – | Sell |
-317
| Closed | -$221K | – | 256 |
|
|
2022
Q1 | $221K | Hold |
317
| – | – | 0.01% | 242 |
|
|
2021
Q4 | $200K | Buy |
+317
| New | +$200K | 0.01% | 253 |
|